2020-11-11 13:15:07
Reference is made to the notice published on NOTC on 6 November 2020 in which it was informed that ImmunoPharma has requested an extraordinary general meeting to resolve a
de-listing of Eqology's shares from NOTC during December 2020.
The board of Eqology AS has resolved to comply with the request, and call for an extraordinary general meeting to be held on 20 November 2020 at 1 pm CET, at the companys premises in Lilleakerveien 2B, 0283 Oslo.
Due to the current measures in force to contain the spread of Covid-19, shareholders are encouraged to refrain from attending in person, and instead participate electronically or by granting a proxy in advance.
The notice of the extraordinary general meeting is attached.
For questions, contact:
Roar Arnstad
CEO
E-mail: roar.arnstad@eqology.no
Christian Espeseth
Chairman of the board